Biopsy Devices Market Report
Published Date: 22 April 2026 | Report Code: biopsy-devices
Biopsy Devices Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the biopsy devices market, which encompasses size estimates, trends, opportunities, and competitive landscape from 2023 to 2033.
Key Takeaways
- Global market expands from $8.40 Billion in 2023 to $14.10 Billion in 2033 at a 5.2% CAGR.
- North America is both the largest and the fastest-growing region, rising from $2.9 Billion in 2023 to $4.86 Billion in 2033.
- Europe and Asia Pacific show substantial mid-decade growth: Europe from $2.76 Billion to $4.63 Billion; Asia Pacific from $1.52 Billion to $2.55 Billion.
- Hospitals, diagnostic laboratories, and academic institutions remain primary end users; needle, surgical, and endoscopic devices are key product categories.
- Leading companies include Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, and Becton, Dickinson and Company.
Biopsy Devices Market Report — Executive Summary
This report presents a focused assessment of the biopsy devices market between 2023 and 2033. The market is estimated at $8.40 Billion in 2023 and is projected to reach $14.10 Billion by 2033 at a 5.2% CAGR. Expansion is supported by clinical demand for accurate tissue sampling, advances in image-guided and robotic-assisted techniques, and a shift toward less invasive procedures. The analysis covers technology classes, device types, clinical applications such as oncology and cardiology, and end-user adoption across hospitals, diagnostic laboratories, and academic institutions. Regional breakdown highlights North America as the dominant and fastest-growing market, with Europe and Asia Pacific also contributing notable growth. Competitive profiling focuses on major participants including Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, and Becton, Dickinson and Company. Methodology blends expert interviews, company documentation, and data triangulation to ensure robust findings for stakeholders evaluating investment, product development, and market-entry strategies.
Key Growth Drivers
- Rising demand for precise diagnostics driven by growing incidence of chronic and oncologic conditions.
- Advancements in imaging and robotic-assisted platforms that improve sampling accuracy and procedural efficiency.
- Shifts toward minimally invasive procedures that reduce patient recovery time and procedural complications.
- Investment in research and development and strategic activity by leading firms to expand product portfolios and clinical applications.
- Increased adoption in hospitals and diagnostic laboratories due to expanding screening and surveillance programs.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $8.40 Billion |
| CAGR (2023-2033) | 5.2% |
| 2033 Market Size | $14.10 Billion |
| Top Companies | Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, Becton, Dickinson and Company |
| Last Modified Date | 22 April 2026 |
Biopsy Devices Market Overview
Customize Biopsy Devices Market Report market research report
- ✔ Get in-depth analysis of Biopsy Devices market size, growth, and forecasts.
- ✔ Understand Biopsy Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biopsy Devices
What is the Market Size & CAGR of Biopsy Devices Market Report market in 2023?
Biopsy Devices Industry Analysis
Biopsy Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biopsy Devices Market Report Market Analysis Report by Region
Europe Biopsy Devices Market Report:
Europe grows from $2.76 Billion in 2023 to $4.63 Billion in 2033. Expansion reflects increased screening programs, investments in minimally invasive procedures, and adoption of imaging technologies within hospital and diagnostic laboratory settings.Asia Pacific Biopsy Devices Market Report:
Asia Pacific advances from $1.52 Billion in 2023 to $2.55 Billion in 2033. Market expansion is tied to growing healthcare access, rising diagnostic capacity, and increasing use of modern biopsy techniques in tertiary care centers.North America Biopsy Devices Market Report:
North America is the largest and fastest-growing region, with market value rising from $2.9 Billion in 2023 to $4.86 Billion in 2033. Regional momentum is driven by advanced clinical infrastructure, rapid adoption of image-guided and robotic-assisted systems, and strong presence of leading companies supporting innovation and commercialization.South America Biopsy Devices Market Report:
Middle East & Africa Biopsy Devices Market Report:
Middle East and Africa rise from $0.4 Billion in 2023 to $0.66 Billion in 2033. Market gains are driven by improving healthcare infrastructure, targeted investments in diagnostic capabilities, and incremental adoption of newer biopsy technologies.Tell us your focus area and get a customized research report.
Research Methodology
Biopsy Devices Market Analysis By Device Type
In 2023, the needle biopsy segment was valued at $5.16 billion, accounting for 61.39% market share, and is expected to grow to $8.66 billion by 2033. Surgical biopsy follows with $1.86 billion in 2023, expected to reach $3.12 billion by 2033. Endoscopic biopsy is also growing from $1.38 billion to $2.32 billion over the same period.
Biopsy Devices Market Analysis By Technology
Image-guided biopsy, representing 61.39% share in 2023 with a market size of $5.16 billion, is anticipated to grow to $8.66 billion by 2033. Robotic-assisted biopsy, accounting for about 22.16% share with a market value of $1.86 billion, is expected to reach $3.12 billion by 2033, representing a significant technological advancement in the sector.
Biopsy Devices Market Analysis By End User
Hospitals dominate the end-user segment, holding a market size of $5.16 billion in 2023, projected to grow to $8.66 billion by 2033, accounting for 61.39% market share. Diagnostic laboratories and academic institutions follow, expected to grow from $1.86 billion to $3.12 billion and $1.38 billion to $2.32 billion respectively.
Biopsy Devices Market Analysis By Application
Oncology is the leading application area, with market sizes of $4.34 billion in 2023 expected to increase to $7.29 billion by 2033, representing a 51.68% share. The cardiology market is also vital, growing from $2.06 billion to $3.46 billion in the same period.
Biopsy Devices Market Analysis By Region
Global Biopsy Devices Market, By Region Market Analysis (2023 - 2033)
Regional analysis shows that North America holds the largest market share due to advanced healthcare systems, while Asia Pacific is growing rapidly due to increasing healthcare investments. Europe presents substantial growth opportunities with high R&D expenditure, while Latin America focuses on enhancing healthcare access.
Biopsy Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biopsy Devices Industry
Thermo Fisher Scientific Inc.:
A leading provider of innovative diagnostic solutions, they are committed to advancing the healthcare landscape through research and development.Danaher Corporation:
Known for its precision instruments, Danaher's technologies improve the quality of biopsies through analytical advancements.Boston Scientific Corporation:
A global leader in medical devices, Boston Scientific offers diverse biopsy solutions and actively invests in R&D.Becton, Dickinson and Company:
BD is highly regarded for its biopsy needles and related products, known for their quality and performance in diagnostics.We're grateful to work with incredible clients.
FAQs
What is the current market size of the biopsy devices market?
The global biopsy devices market size was $8.40 Billion in 2023, based on the report's baseline valuation for that year.
How big will the biopsy devices market be by 2033?
By 2033 the market is projected to reach $14.10 Billion, reflecting the forecast provided for the 2023 to 2033 period.
What is CAGR of the biopsy devices market for 2023 to 2033?
The market is expected to grow at a compound annual growth rate of 5.2% over the 2023 to 2033 forecast horizon.
Which region is the largest for biopsy devices?
North America is identified as the largest region, with its market increasing from $2.9 Billion in 2023 to $4.86 Billion in 2033.
Which is the fastest Growing region for biopsy devices?
North America is also noted as the fastest-growing region in the forecast, expanding significantly between 2023 and 2033.
Who are the top companies in the biopsy devices market?
Key market participants named include Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, and Becton, Dickinson and Company.
Why are hospitals important end users for biopsy devices?
Hospitals account for substantial procedure volume and have the infrastructure to support advanced imaging and minimally invasive techniques, making them primary adopters of biopsy devices.
What are the main device types covered in the market?
The report covers primary device types including needle biopsy, surgical biopsy, and endoscopic biopsy as central categories of market offering.
How are technology trends shaping the market?
Emerging image-guided and robotic-assisted modalities, alongside improvements in traditional techniques, are influencing device development and clinical adoption decisions.